Skip to main content
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1995 Jan;99(1):106–111. doi: 10.1111/j.1365-2249.1995.tb03479.x

IL-8 release from cultured peripheral blood monocytes of patients with glomerulonephritis.

K Matsumoto 1
PMCID: PMC1534141  PMID: 7813101

Abstract

IL-8 is a chemotactic cytokine with proinflammatory and growth-promoting activities. The release of IL-8 was measured in supernatants of cultured peripheral blood monocytes (PBM) that were obtained from patients with glomerulonephritis (GN) and healthy controls. Spontaneous and lipopolysaccharide (LPS)-induced IL-8 release was significantly higher in PBM isolated from patients with IgA nephropathy (IgAN) and membranous nephropathy (MN) compared with normal controls. These results raise the question of whether IL-8 contributes to the ongoing pathogenesis of GN. We cannot relate IL-8 release to clinical and laboratory parameters in IgAN and MN patients. Thus, disease progression in vivo may not be accompanied by increased or sustained IL-8 release.

Full text

PDF
106

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abbott F., Ryan J. J., Ceska M., Matsushima K., Sarraf C. E., Rees A. J. Interleukin-1 beta stimulates human mesangial cells to synthesize and release interleukins-6 and -8. Kidney Int. 1991 Oct;40(4):597–605. doi: 10.1038/ki.1991.250. [DOI] [PubMed] [Google Scholar]
  2. Brown Z., Strieter R. M., Chensue S. W., Ceska M., Lindley I., Neild G. H., Kunkel S. L., Westwick J. Cytokine-activated human mesangial cells generate the neutrophil chemoattractant, interleukin 8. Kidney Int. 1991 Jul;40(1):86–90. doi: 10.1038/ki.1991.184. [DOI] [PubMed] [Google Scholar]
  3. Kusner D. J., Luebbers E. L., Nowinski R. J., Konieczkowski M., King C. H., Sedor J. R. Cytokine- and LPS-induced synthesis of interleukin-8 from human mesangial cells. Kidney Int. 1991 Jun;39(6):1240–1248. doi: 10.1038/ki.1991.157. [DOI] [PubMed] [Google Scholar]
  4. Matsumoto K., Dowling J., Atkins R. C. Production of interleukin 1 in glomerular cell cultures from patients with rapidly progressive crescentic glomerulonephritis. Am J Nephrol. 1988;8(6):463–470. doi: 10.1159/000167656. [DOI] [PubMed] [Google Scholar]
  5. Matsumoto K. Increased release of tumor necrosis factor-alpha by monocytes from patients with glomerulonephritis. Clin Nephrol. 1993 Sep;40(3):148–154. [PubMed] [Google Scholar]
  6. Matsumoto K. Interleukin-1 production by monocytes from patients with glomerulonephritis after stimulation in vitro with soluble immune complexes. Clin Nephrol. 1991 Dec;36(6):267–273. [PubMed] [Google Scholar]
  7. Matsumoto K. Production of interleukin-1 by glomerular macrophages in nephrotoxic serum nephritis. Am J Nephrol. 1990;10(6):502–506. doi: 10.1159/000168176. [DOI] [PubMed] [Google Scholar]
  8. Matsumoto K. Production of tumor necrosis factor-alpha by glomerular macrophages in nephrotoxic serum nephritis. Clin Nephrol. 1992 Oct;38(4):237–238. [PubMed] [Google Scholar]
  9. Schröder J. M., Mrowietz U., Morita E., Christophers E. Purification and partial biochemical characterization of a human monocyte-derived, neutrophil-activating peptide that lacks interleukin 1 activity. J Immunol. 1987 Nov 15;139(10):3474–3483. [PubMed] [Google Scholar]
  10. Werber H. I., Emancipator S. N., Tykocinski M. L., Sedor J. R. The interleukin 1 gene is expressed by rat glomerular mesangial cells and is augmented in immune complex glomerulonephritis. J Immunol. 1987 May 15;138(10):3207–3212. [PubMed] [Google Scholar]
  11. Zoja C., Wang J. M., Bettoni S., Sironi M., Renzi D., Chiaffarino F., Abboud H. E., Van Damme J., Mantovani A., Remuzzi G. Interleukin-1 beta and tumor necrosis factor-alpha induce gene expression and production of leukocyte chemotactic factors, colony-stimulating factors, and interleukin-6 in human mesangial cells. Am J Pathol. 1991 Apr;138(4):991–1003. [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES